- Home
- ITRM vs REVG Comparison
ITRM vs REVG Comparison
Compare ITRM & REVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRM | REVG |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 2.9B |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ITRM | REVG |
|---|---|---|
| Price | $0.47 | $58.61 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 4 |
| Target Price | $9.00 | ★ $48.00 |
| AVG Volume (30 Days) | ★ 1.2M | 861.2K |
| Earning Date | 11-14-2025 | 12-10-2025 |
| Dividend Yield | N/A | ★ 0.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.89 |
| Revenue | $390,000.00 | ★ $2,463,500,000.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | $325.95 | $7.49 |
| P/E Ratio | ★ N/A | $31.60 |
| Revenue Growth | N/A | ★ 3.50 |
| 52 Week Low | $0.36 | $26.51 |
| 52 Week High | $2.27 | $64.47 |
Technical Indicators
Market Signals| Indicator | ITRM | REVG |
|---|---|---|
| Relative Strength Index (RSI) | 44.52 | 62.75 |
| Support Level | $0.44 | $55.46 |
| Resistance Level | $0.48 | $57.64 |
| Average True Range (ATR) | 0.04 | 1.74 |
| MACD | 0.01 | 0.79 |
| Stochastic Oscillator | 43.56 | 83.72 |
Price Performance
Historical ComparisonAbout ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About REVG REV Group Inc.
REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.